
![]() |
|||||||||||||
WJPR Citation
|
| All | Since 2020 | |
| Citation | 8502 | 4519 |
| h-index | 30 | 23 |
| i10-index | 227 | 96 |
DIFFERENTIAL EXPRESSION OF CARDIAC BIOMARKER BASED ON GENDER, AGE, DIABETIC, BLOOD PRESSURE, SMOKING AND DRINKING IN PATIENTS OF MYOCARDIAL INFARCTION.
V. Pushpa Rani*, K. Shanmuga Priya, A. Anitha Nancy and G. Meena Kumari
Abstract The ideal serum marker for myocardial injury would be specific to myocardium, highly sensitive and quantitative with rapidly increased serum levels for early diagnosis. The first account of the use of a biochemical marker in the study of myocardial injury was published by La Due and colleagues in the journal Science in 1954. The study is carried out in 65 myocardial patients, the objective of the study to evaluate these cardiac markers and their significance effect of these enzymes in gender (Male & Female), age (70), diabetic (Diabetic & Non-diabetic patients), Blood Pressure (Normal & Abnormal B P patients), smoking (Smokers & Nonsmokers), and drinking (Drunkard & Teetotaler). Male and female affected by myocardial infarction has no much difference in the cardiac enzymes in the blood. The different age group of myocardial patients has not shown much variation in the level of cardiac marker. Smoking, drinking, diabetics and blood pressure increase the risk of getting myocardial infarction. Keywords: myocardial infarction, cardiac marker, Creatinine Kinase, CK-NAC, LDH, SGOT and SGPT. [Full Text Article] [Download Certificate] |
